Literature DB >> 12171817

Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia.

Keisaku Fujimoto1, Yukinori Matsuzawa, Shinji Yamaguchi, Tomonobu Koizumi, Keishi Kubo.   

Abstract

STUDY
OBJECTIVES: To clarify the effects of oxygen on exercise performance and pulmonary hemodynamics during exercise in patients with COPD with mild hypoxemia at rest.
DESIGN: Seventy-five male patients with stable COPD ("pink puffer" type), accompanied by mild hypoxemia (> 60 mm Hg) at rest and with mild (percentage of predicted FEV1 [%FEV1] > 50%, n = 16), moderate (%FEV1 > 35% to < or = 50%, n = 25), and severe (%FEV1 < or =35%, n = 34) airflow obstruction were recruited from an outpatient clinic. A 6-min walking distance (6MD) test was administered to 75 patients, and the pulmonary hemodynamics of 43 subjects were determined during exercise on a supine bicycle ergometer at 25 W and breathing compressed air and oxygen at 2 L/min.
RESULTS: Supplemental oxygen resulted in a significant increase in 6MD, except for patients with mild airflow obstruction and mild desaturation. This increase in 6MD produced by oxygen was greater as the restriction of the airflow was more severe, and correlated negatively with %FEV1, but not with PaO2 at rest or exercise hypoxemia. Pulmonary artery pressure (Ppa) and pulmonary artery occlusion pressure (Pop) increased with exercise, while the rates of increase in both types of pressure were significantly higher for severe COPD than for mild COPD and moderate COPD. Oxygen inhalation significantly reduced the increases in Ppa and Pop during exercise in patients with moderate-to-severe COPD, and the effect of oxygen on the increase in Pop correlated positively with airtrapping (vital capacity - FVC).
CONCLUSION: These findings suggest that supplemental oxygen benefits patients with COPD with moderate-to-severe airflow obstruction and mild hypoxemia at rest, as reflected in improvement in exercise performance and pulmonary hypertension during exercise.

Entities:  

Mesh:

Year:  2002        PMID: 12171817     DOI: 10.1378/chest.122.2.457

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

Review 1.  Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest.

Authors:  Faisal Ameer; Kristin V Carson; Zafar A Usmani; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2014-06-24

2.  Effects of a Highly Portable Noninvasive Open Ventilation System on Activities of Daily Living in Patients with COPD.

Authors:  Brian W Carlin; Kimberly S Wiles; Robert W McCoy; Toni Brennan; Dan Easley; Richard J Thomashow
Journal:  Chronic Obstr Pulm Dis       Date:  2015-01-01

Review 3.  Oxygen therapy for COPD.

Authors:  Christine F McDonald
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

4.  Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography.

Authors:  Young Kyung Lee; Yeon-Mok Oh; Ji-Hyun Lee; Eun Kyung Kim; Jin Hwa Lee; Namkug Kim; Joon Beom Seo; Sang Do Lee
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

5.  Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Authors:  Angelo M Taveira-DaSilva; Olanda M Hathaway; Vandana Sachdev; Yukitaka Shizukuda; Charles W Birdsall; Joel Moss
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

6.  Does prior training affect acute O₂ supply responses during exercise in Desaturator COPD patients?

Authors:  Delphine Delample; Meritxell Sabate; Christian Préfaut; Fabienne Durand
Journal:  Open Respir Med J       Date:  2008-03-13

Review 7.  Pulmonary hypertension and chronic cor pulmonale in COPD.

Authors:  Adil Shujaat; Ruth Minkin; Edward Eden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 8.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Neutrophilic Alveolitis and High Serum Pro-Brain Natriuretic Peptide Level may be Indicators of Pulmonary Functional Impairment in Connective Tissue Disorders.

Authors:  Serap Unculu; Özlem Erçen Diken; Aydın Çiledağ; Aydan Ikincioğullari; Demet Karnak; Oya Kayacan; Murat Turgay
Journal:  Arch Rheumatol       Date:  2015-08-31       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.